Cite
HARVARD Citation
Abozguia, K. et al. (n.d.). 061 Metabolic alteration in hypertrophic cardiomyopathy (METAL-HCM Study): randomised double blinded placebo controlled trial of perhexiline therapy in patient with hypertrophic cardiomyopathy. Heart. p. A36. [Online].